Nervgen Pharma Corp Stock Buy Hold or Sell Recommendation
| NGENF Stock | USD 1.59 0.14 9.66% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding NervGen Pharma Corp is 'Strong Sell'. Macroaxis provides NervGen Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NGENF positions. The advice algorithm takes into account all of NervGen Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting NervGen Pharma's buy or sell advice are summarized below:
Real Value 1.5 | Hype Value 1.59 | Market Value 1.59 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell NervGen Pharma Corp given historical horizon and risk tolerance towards NervGen Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for NervGen Pharma Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
NervGen |
Execute NervGen Pharma Buy or Sell Advice
The NervGen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NervGen Pharma Corp. Macroaxis does not own or have any residual interests in NervGen Pharma Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NervGen Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
NervGen Pharma Trading Alerts and Improvement Suggestions
| NervGen Pharma Corp generated a negative expected return over the last 90 days | |
| NervGen Pharma Corp has high historical volatility and very poor performance | |
| NervGen Pharma Corp may become a speculative penny stock | |
| NervGen Pharma Corp has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NervGen Pharma Corp has accumulated about 11.65 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
NervGen Pharma Returns Distribution Density
The distribution of NervGen Pharma's historical returns is an attempt to chart the uncertainty of NervGen Pharma's future price movements. The chart of the probability distribution of NervGen Pharma daily returns describes the distribution of returns around its average expected value. We use NervGen Pharma Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NervGen Pharma returns is essential to provide solid investment advice for NervGen Pharma.
| Mean Return | -0.17 | Value At Risk | -7.14 | Potential Upside | 8.46 | Standard Deviation | 5.14 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NervGen Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NervGen Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NervGen Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NervGen Pharma's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NervGen otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.3 | |
β | Beta against NYSE Composite | 1.60 | |
σ | Overall volatility | 5.30 | |
Ir | Information ratio | -0.05 |
NervGen Pharma Volatility Alert
NervGen Pharma Corp exhibits very low volatility with skewness of 1.16 and kurtosis of 2.98. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NervGen Pharma's otc stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NervGen Pharma's otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NervGen Pharma Fundamentals Vs Peers
Comparing NervGen Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NervGen Pharma's direct or indirect competition across all of the common fundamentals between NervGen Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as NervGen Pharma or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of NervGen Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing NervGen Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare NervGen Pharma to competition |
| Fundamentals | NervGen Pharma | Peer Average |
| Return On Equity | -1.42 | -0.31 |
| Return On Asset | -0.67 | -0.14 |
| Current Valuation | 48.78 M | 16.62 B |
| Shares Outstanding | 58.68 M | 571.82 M |
| Shares Owned By Insiders | 25.27 % | 10.09 % |
| Price To Book | 5.13 X | 9.51 X |
| EBITDA | (11.33 M) | 3.9 B |
| Net Income | (12.73 M) | 570.98 M |
| Cash And Equivalents | 11.65 M | 2.7 B |
| Cash Per Share | 0.20 X | 5.01 X |
| Total Debt | 324.69 K | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 4.25 X | 2.16 X |
| Book Value Per Share | 0.31 X | 1.93 K |
| Cash Flow From Operations | (8.27 M) | 971.22 M |
| Earnings Per Share | (0.28) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | 1.7 | -0.15 |
| Market Capitalization | 87.43 M | 19.03 B |
| Total Asset | 17.9 M | 29.47 B |
| Net Asset | 17.9 M |
NervGen Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NervGen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About NervGen Pharma Buy or Sell Advice
When is the right time to buy or sell NervGen Pharma Corp? Buying financial instruments such as NervGen OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NervGen Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electrical Equipment Thematic Idea Now
Electrical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electrical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electrical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out NervGen Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for NervGen OTC Stock analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |